NCT05809544

Brief Summary

The purpose of the study was to determine safety and efficacy of WELT-IP in adult insomnia patients. WELT-IP is a cognitive behavioral therapy for insomnia (CBT-I) based digital therapeutics.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
68

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 14, 2022

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 20, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 20, 2023

Completed
21 days until next milestone

First Submitted

Initial submission to the registry

March 13, 2023

Completed
1 month until next milestone

First Posted

Study publicly available on registry

April 12, 2023

Completed
Last Updated

April 12, 2023

Status Verified

March 1, 2023

Enrollment Period

4 months

First QC Date

March 13, 2023

Last Update Submit

April 9, 2023

Conditions

Keywords

digital therapeutics

Outcome Measures

Primary Outcomes (1)

  • Change from baseline to week 7 (post-treatment) of Sleep efficiency(SE)

    Sleep efficiency is calculated as percentage of Total sleep time/Time in bed.

    7 weeks

Secondary Outcomes (11)

  • Change from baseline to week 7 (post-treatment) of Sleep quality (SQ)

    7 weeks

  • Change from baseline to week 7 (post-treatment) of Sleep onset latency (SOL)

    7 weeks

  • Change from baseline to week 7 (post-treatment) of Wake after sleep onset (WASO)

    7 weeks

  • Change from baseline to week 7 (post-treatment) of Total sleep time (TST)

    7 weeks

  • Change from baseline to week 7 (post-treatment) of Number of awakening (NOA)

    7 weeks

  • +6 more secondary outcomes

Other Outcomes (3)

  • App Satisfaction Survey

    7 weeks

  • Sleep Environment Survey

    7 weeks

  • Activity data from mobile device

    7 weeks

Study Arms (2)

WELT-IP

EXPERIMENTAL

Eligible subjects were able to access WELT-IP (an investigational digital therapeutic) on a mobile device (iOS and Android) as scheduled to receive CBT-I.

Device: WELT-IP

Sham

SHAM COMPARATOR

Eligible subjects were able to access a sham app downloaded on a mobile device (iOS and Android) which included sleep diary and general content regarding sleep.

Device: Sham

Interventions

WELT-IPDEVICE

WELT-IP (an investigational digital therapeutic) is an CBT-I based intervention designed to treat insomnia, conducted in 6 sessions. It is a comprehensive program delivering sleep restriction, stimulation control, muscle relaxation, cognitive treatment, and sleep hygiene education. Main features are sleep diary, sleep reports, daily lessons of CBT-I, muscle relaxation techniques, and cognitive intervention through chatbot.

WELT-IP
ShamDEVICE

Sham was downloaded to the subject's phone and was subject was instructed to complete sleep diary and sleep educational contents as needed.

Sham

Eligibility Criteria

Age19 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • DSM-5 insomnia patient
  • SE (sleep efficiency) \<80%
  • completing screening sleep diary of 7 consecutive days
  • ISI of 8 or above
  • capable of using mobile device and application

You may not qualify if:

  • currently on non-pharmacological treatment for insomnia (ex. CBT-I, light therapy, oriental therapy for insomnia)
  • sleep disorders diagnosis other than insomnia (ex. Obstructive sleep apnea, sleep behavior problem, restless leg syndrome)
  • progressive and active medical conditions
  • received continuous psychotherapy such as CBT, motivational enhancement therapy, psychotherapy, and psychoanalysis in the past 3 months
  • major psychiatric illness as assessed through MINI
  • suicide risk as assessed through C-SSRS
  • having occupational risk due to sleep restriction
  • shift workers

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Severance Hospital

Seoul, 03722, South Korea

Location

Related Publications (1)

  • Lee S, Park KM, Lee DH, Choi EC, Lee Y, Lee E. Impact of Adherence to Digital Cognitive Behavioral Therapy for Insomnia Effectiveness. Yonsei Med J. 2025 Oct;66(10):657-665. doi: 10.3349/ymj.2024.0398.

MeSH Terms

Conditions

Sleep Initiation and Maintenance Disorders

Condition Hierarchy (Ancestors)

Sleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesMental Disorders

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Masking Details
double-blinded
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: This is a randomized, double-blinded design, with three points of measurement. The subjects will receive either the WELT-IP app or sham app.
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 13, 2023

First Posted

April 12, 2023

Study Start

October 14, 2022

Primary Completion

February 20, 2023

Study Completion

February 20, 2023

Last Updated

April 12, 2023

Record last verified: 2023-03

Data Sharing

IPD Sharing
Will not share

Locations